EPOC

Welcome to the website for the European Paediatric Oncology Off-Patent Medicines Consortium (EPOC).  On this website you can find details of the EPOC-doxorubicin trial (EudraCT 2009-011454-17, ClinicalTrials.gov id NCT01095926), a phase II pharmacokinetic study to assess the age-dependency in the clearance of doxorubicin in paediatric patients with solid tumours and leukaemia, performed within EPOC. 

The EPOC consortium, with collaborators in the UK, Germany, France and Italy, obtained funding within the seventh framework of the European Commission (FP7) to perform paediatric oncology pharmacology clinical trials.

The EPOC-doxorubicin trial is sponsored by the University Hospital Münster in Germany and the Coordinating Investigator is Prof Joachim Boos.